KMT2A and lung carcinoma: Targeted next-generation sequencing approaches (NGS) have proven to be affective in the detection of chromosomal aberrations like translocation of ALK and lysine methyltransferase 2A (KMT2A) in lung carcinoma, anaplastic large cell carcinoma and acute leukemias [9].